$26.38
+0.51 (+1.97%)
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Price Target
Analyst Price Target
+135.3% upside
Low Target
$37.88
Average Target
$62.07
High Target
$80.69
Current Price
$26.38
Current
$26.38
$26.38
Target
$62.07
$62.07
$37.88
$62.07 avg
$80.69
Scenario Analysis
Bear Case
$37.88
43.6%
Low target
Base Case
$62.07
+135.3%
Avg target
Bull Case
$80.69
+205.9%
High target
Risk/Reward
4.7x
Highly favorable
Price in Context
52-Week High
$38.26
-31.1% from high
52-Week Low
$20.23
+30.4% from low
50-Day SMA
$25.58
+3.1% vs SMA
200-Day SMA
$28.00
-5.8% vs SMA
RSI (14)
57.8
Neutral
Target vs 52W High
$62.07
+62.2% vs high
Next Earnings Report
Nov 9, 2026
1d
tomorrow
EPS Est: $-1.18
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |